Cargando…
The internal dosimetry user group position statement on molecular radiotherapy
The Internal Dosimetry User Group (IDUG) is an independent, non-profit group of medical professionals dedicated to the promotion of dosimetry in molecular radiotherapy (www.IDUG.org.uk). The Ionising Radiation (Medical Exposure) Regulations 2017, IR(ME)R, stipulate a requirement for optimisation and...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Institute of Radiology.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328072/ https://www.ncbi.nlm.nih.gov/pubmed/34433005 http://dx.doi.org/10.1259/bjr.20210547 |
_version_ | 1784757632608763904 |
---|---|
author | Gear, Jonathan McGowan, Daniel Rojas, Bruno Craig, Allison J Smith, April-Louise Scott, Catherine J Scuffam, James Aldridge, Matthew Tipping, Jill |
author_facet | Gear, Jonathan McGowan, Daniel Rojas, Bruno Craig, Allison J Smith, April-Louise Scott, Catherine J Scuffam, James Aldridge, Matthew Tipping, Jill |
author_sort | Gear, Jonathan |
collection | PubMed |
description | The Internal Dosimetry User Group (IDUG) is an independent, non-profit group of medical professionals dedicated to the promotion of dosimetry in molecular radiotherapy (www.IDUG.org.uk). The Ionising Radiation (Medical Exposure) Regulations 2017, IR(ME)R, stipulate a requirement for optimisation and verification of molecular radiotherapy treatments, ensuring doses to non-target organs are as low as reasonably practicable. For many molecular radiotherapy treatments currently undertaken within the UK, this requirement is not being fully met. The growth of this field is such that we risk digressing further from IR(ME)R compliance potentially delivering suboptimal therapies that are not in the best interest of our patients. For this purpose, IDUG proposes ten points of action to aid in the successful implementation of this legislation. We urge stakeholders to support these proposals and ensure national provision is sufficient to meet the criteria necessary for compliance, and for the future advancement of molecular radiotherapy within the UK. |
format | Online Article Text |
id | pubmed-9328072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The British Institute of Radiology. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93280722022-08-05 The internal dosimetry user group position statement on molecular radiotherapy Gear, Jonathan McGowan, Daniel Rojas, Bruno Craig, Allison J Smith, April-Louise Scott, Catherine J Scuffam, James Aldridge, Matthew Tipping, Jill Br J Radiol Guidelines & Recommendations The Internal Dosimetry User Group (IDUG) is an independent, non-profit group of medical professionals dedicated to the promotion of dosimetry in molecular radiotherapy (www.IDUG.org.uk). The Ionising Radiation (Medical Exposure) Regulations 2017, IR(ME)R, stipulate a requirement for optimisation and verification of molecular radiotherapy treatments, ensuring doses to non-target organs are as low as reasonably practicable. For many molecular radiotherapy treatments currently undertaken within the UK, this requirement is not being fully met. The growth of this field is such that we risk digressing further from IR(ME)R compliance potentially delivering suboptimal therapies that are not in the best interest of our patients. For this purpose, IDUG proposes ten points of action to aid in the successful implementation of this legislation. We urge stakeholders to support these proposals and ensure national provision is sufficient to meet the criteria necessary for compliance, and for the future advancement of molecular radiotherapy within the UK. The British Institute of Radiology. 2021-10-01 2022-07-08 /pmc/articles/PMC9328072/ /pubmed/34433005 http://dx.doi.org/10.1259/bjr.20210547 Text en © 2021 The Authors. Published by the British Institute of Radiology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 Unported License http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial reuse, provided the original author and source are credited. |
spellingShingle | Guidelines & Recommendations Gear, Jonathan McGowan, Daniel Rojas, Bruno Craig, Allison J Smith, April-Louise Scott, Catherine J Scuffam, James Aldridge, Matthew Tipping, Jill The internal dosimetry user group position statement on molecular radiotherapy |
title | The internal dosimetry user group position statement on molecular radiotherapy |
title_full | The internal dosimetry user group position statement on molecular radiotherapy |
title_fullStr | The internal dosimetry user group position statement on molecular radiotherapy |
title_full_unstemmed | The internal dosimetry user group position statement on molecular radiotherapy |
title_short | The internal dosimetry user group position statement on molecular radiotherapy |
title_sort | internal dosimetry user group position statement on molecular radiotherapy |
topic | Guidelines & Recommendations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328072/ https://www.ncbi.nlm.nih.gov/pubmed/34433005 http://dx.doi.org/10.1259/bjr.20210547 |
work_keys_str_mv | AT gearjonathan theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy AT mcgowandaniel theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy AT rojasbruno theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy AT craigallisonj theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy AT smithaprillouise theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy AT scottcatherinej theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy AT scuffamjames theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy AT aldridgematthew theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy AT tippingjill theinternaldosimetryusergrouppositionstatementonmolecularradiotherapy AT gearjonathan internaldosimetryusergrouppositionstatementonmolecularradiotherapy AT mcgowandaniel internaldosimetryusergrouppositionstatementonmolecularradiotherapy AT rojasbruno internaldosimetryusergrouppositionstatementonmolecularradiotherapy AT craigallisonj internaldosimetryusergrouppositionstatementonmolecularradiotherapy AT smithaprillouise internaldosimetryusergrouppositionstatementonmolecularradiotherapy AT scottcatherinej internaldosimetryusergrouppositionstatementonmolecularradiotherapy AT scuffamjames internaldosimetryusergrouppositionstatementonmolecularradiotherapy AT aldridgematthew internaldosimetryusergrouppositionstatementonmolecularradiotherapy AT tippingjill internaldosimetryusergrouppositionstatementonmolecularradiotherapy |